Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:NNOX NASDAQ:SNWV OTCMKTS:VASO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$4.95$6.30$4.37▼$11.30$131.35M0.8246,978 shs293,201 shsNNOXNano-X Imaging$1.67$1.91$1.59▼$5.69$116.22M1.211.12 million shs1.47 million shsSNWVSanuwave Health$9.21$16.17$8.30▼$46.58$79.20M1.34151,285 shs290,687 shsVASOVaso$0.18$0.19$0.11▼$0.25$32.38M0.5659,391 shs16,846 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%-1.59%-18.32%-43.04%-15.09%NNOXNano-X Imaging0.00%-5.11%-7.73%-30.71%-66.93%SNWVSanuwave Health0.00%-38.23%-45.01%-54.41%-72.09%VASOVaso0.00%-3.16%-19.30%+5.87%+37.72%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$4.95$6.30$4.37▼$11.30$131.35M0.8246,978 shs293,201 shsNNOXNano-X Imaging$1.67$1.91$1.59▼$5.69$116.22M1.211.12 million shs1.47 million shsSNWVSanuwave Health$9.21$16.17$8.30▼$46.58$79.20M1.34151,285 shs290,687 shsVASOVaso$0.18$0.19$0.11▼$0.25$32.38M0.5659,391 shs16,846 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%-1.59%-18.32%-43.04%-15.09%NNOXNano-X Imaging0.00%-5.11%-7.73%-30.71%-66.93%SNWVSanuwave Health0.00%-38.23%-45.01%-54.41%-72.09%VASOVaso0.00%-3.16%-19.30%+5.87%+37.72%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 3.00Buy$11.50132.32% UpsideNNOXNano-X Imaging 2.83Moderate Buy$5.00199.40% UpsideSNWVSanuwave Health 2.50Moderate Buy$51.00453.75% UpsideVASOVaso 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VASO, CVRX, SNWV, and NNOX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026CVRXCVRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/22/2026NNOXNano-X Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell4/20/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/14/2026CVRXCVRx Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.004/13/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/10/2026NNOXNano-X Imaging Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/30/2026SNWVSanuwave Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/30/2026SNWVSanuwave Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$53.00 ➝ $47.003/27/2026SNWVSanuwave Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)(Data available from 6/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$56.65M2.32N/AN/A$1.50 per share3.30NNOXNano-X Imaging$13.02M8.93N/AN/A$2.01 per share0.83SNWVSanuwave Health$44.05M1.80$1.70 per share5.43$0.19 per share48.47VASOVaso$89.10M0.36$0.04 per share4.58$0.17 per share1.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$53.31M-$2.02N/AN/AN/A-89.14%-120.76%-48.38%8/4/2026 (Estimated)NNOXNano-X Imaging-$75.02M-$1.59N/AN/AN/A-790.87%-64.65%-57.27%7/20/2026 (Estimated)SNWVSanuwave Health$11.81M$0.3327.91N/AN/A35.96%-450.56%44.87%8/14/2026 (Estimated)VASOVaso$1.57M$0.0118.42N/AN/A1.97%6.23%2.08%N/ALatest VASO, CVRX, SNWV, and NNOX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026VASOVasoN/A$999.00N/A$999.00N/A$19.36 million5/12/2026Q1 2026SNWVSanuwave Health-$0.14-$0.17-$0.03-$0.17$9.60 million$9.62 million5/11/2026Q1 2026CVRXCVRx-$0.51-$0.50+$0.01-$0.50$14.49 million$14.77 million4/20/2026Q4 2025NNOXNano-X Imaging-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 million3/31/2026Q4 2025VASOVasoN/A$0.01N/A$0.01N/A$27.02 million3/26/2026Q4 2025SNWVSanuwave Health$0.17$0.03-$0.14$0.6360$13.23 million$13.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/AVASOVasoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx2.0110.208.89NNOXNano-X ImagingN/A3.963.77SNWVSanuwave Health8.151.310.99VASOVasoN/A1.671.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%NNOXNano-X Imaging21.49%SNWVSanuwave Health42.53%VASOVasoN/AInsider OwnershipCompanyInsider OwnershipCVRXCVRx13.90%NNOXNano-X Imaging7.74%SNWVSanuwave Health14.40%VASOVaso43.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.54 million22.85 millionOptionableNNOXNano-X Imaging19069.59 million64.20 millionOptionableSNWVSanuwave Health408.60 million7.36 millionN/AVASOVaso260176.00 million98.82 millionNot OptionableVASO, CVRX, SNWV, and NNOX HeadlinesRecent News About These CompaniesVaso Corporation (VASO) latest stock news and headlines – Yahoo FinanceJune 19 at 5:23 PM | uk.finance.yahoo.comVaso Corporation (OTCMKTS:VASO) Short Interest UpdateJune 13, 2026 | americanbankingnews.comVaso (OTCMKTS:VASO) Shares Pass Above Two Hundred Day Moving Average - Here's What HappenedJune 9, 2026 | americanbankingnews.comVaso Stock Gains Post Q1 Earnings, Deferred Revenue GrowsMay 21, 2026 | zacks.comVaso Corporation Announces Financial Results for First Quarter of 2026May 15, 2026 | globenewswire.comNovo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis ...April 21, 2026 | manilatimes.netMCorn In A Cup (Elote En Vaso) RecipeApril 20, 2026 | yahoo.comVaso Corporation (VASO) stock price, news, quote and history - Yahoo FinanceApril 4, 2026 | sg.finance.yahoo.comVaso Stock Declines Post Q4 Earnings Despite Revenue GrowthApril 2, 2026 | zacks.comVaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025March 31, 2026 | markets.businessinsider.comVaso shareholders reelect directors and adopt triennial say-on-payDecember 19, 2025 | tipranks.comVaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCareDecember 17, 2025 | globenewswire.comPositive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025December 7, 2025 | managedhealthcareexecutive.comMExa-cel shows complete success in early pediatric trials for sickle cell disease and beta-thalassemiaDecember 7, 2025 | news-medical.netNExa-cel gene therapy may off effective cure for beta-thalassemia and sickle cell disease in children younger than 12December 6, 2025 | medicalxpress.comM‘Extremely encouraging’: Exa-cel benefits kids with sickle cell disease, beta thalassemiaDecember 6, 2025 | healio.comHNanox to acquire VHC IT to accelerate AI deployment in USNovember 21, 2025 | msn.comVASO Food Bank serves veterans during time of high food insecurityNovember 21, 2025 | mvskokemedia.comMVaso Sells Subsidiary VasoHealthcare IT to Nano-XNovember 20, 2025 | tipranks.comNanox Imaging to Acquire VasoHealthcare IT for U.S. AI ExpansionNovember 20, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVASO, CVRX, SNWV, and NNOX Company DescriptionsCVRx NASDAQ:CVRX$4.95 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$4.94 0.00 (-0.10%) As of 06/18/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Nano-X Imaging NASDAQ:NNOX$1.67 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$1.70 +0.03 (+1.86%) As of 06/18/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Sanuwave Health NASDAQ:SNWV$9.21 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$9.12 -0.10 (-1.03%) As of 06/18/2026 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Vaso OTCMKTS:VASO$0.18 0.00 (0.00%) As of 06/18/2026 03:11 PM EasternVaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
